DK1109785T3 - Indolderivater og deres anvendelse til behandling af ondartede og andre sygdomme forårsaget af patologisk celleproliferation - Google Patents
Indolderivater og deres anvendelse til behandling af ondartede og andre sygdomme forårsaget af patologisk celleproliferationInfo
- Publication number
- DK1109785T3 DK1109785T3 DK99927711T DK99927711T DK1109785T3 DK 1109785 T3 DK1109785 T3 DK 1109785T3 DK 99927711 T DK99927711 T DK 99927711T DK 99927711 T DK99927711 T DK 99927711T DK 1109785 T3 DK1109785 T3 DK 1109785T3
- Authority
- DK
- Denmark
- Prior art keywords
- malignant
- treatment
- cell proliferation
- diseases caused
- pathological cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/56—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19819835 | 1998-05-04 | ||
| DE19838506A DE19838506C2 (de) | 1998-05-04 | 1998-08-25 | Indolderivate und deren Verwendung zur Behandlung von malignen und anderen, auf pathologischen Zellproliferationen beruhenden Erkrankungen |
| PCT/DE1999/001214 WO1999057117A2 (de) | 1998-05-04 | 1999-04-22 | Indolderivate und deren verwendung zur behandlung von malignen und anderen, auf pathologischen zellproliferationen beruhenden erkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1109785T3 true DK1109785T3 (da) | 2003-04-22 |
Family
ID=26045937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK99927711T DK1109785T3 (da) | 1998-05-04 | 1999-04-22 | Indolderivater og deres anvendelse til behandling af ondartede og andre sygdomme forårsaget af patologisk celleproliferation |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US6407102B1 (da) |
| EP (1) | EP1109785B1 (da) |
| JP (1) | JP2002514572A (da) |
| CN (1) | CN1151127C (da) |
| AT (1) | ATE230394T1 (da) |
| AU (1) | AU752464B2 (da) |
| BG (1) | BG104996A (da) |
| BR (1) | BR9911017A (da) |
| CA (1) | CA2330756C (da) |
| CZ (1) | CZ20003960A3 (da) |
| DE (1) | DE59903921D1 (da) |
| DK (1) | DK1109785T3 (da) |
| ES (1) | ES2190221T3 (da) |
| HK (1) | HK1038354A1 (da) |
| HU (1) | HUP0102563A3 (da) |
| IL (1) | IL139056A0 (da) |
| NO (1) | NO317261B1 (da) |
| NZ (1) | NZ507735A (da) |
| PL (1) | PL346840A1 (da) |
| SK (1) | SK16352000A3 (da) |
| TR (1) | TR200003206T2 (da) |
| WO (1) | WO1999057117A2 (da) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9911017A (pt) | 1998-05-04 | 2001-02-06 | Asta Medica Ag | Derivados de indol e seu emprego para o tratamento de doenças malignas e outras, que se baseiam na proliferação de células patológicas |
| JP2002527419A (ja) * | 1998-10-08 | 2002-08-27 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | Ｇｓｋ−３阻害物質としてのピロール−２，５−ジオン類 |
| US6719520B2 (en) | 1998-10-08 | 2004-04-13 | Smithkline Beecham Corporation | Method and compounds |
| AU2001268051A1 (en) * | 2000-06-28 | 2002-01-08 | Eli Lilly And Company | Spla2 inhibitors |
| KR20030031132A (ko) | 2000-07-28 | 2003-04-18 | 스미또모 세이야꾸 가부시키가이샤 | 피롤 유도체 |
| TW557298B (en) * | 2000-08-14 | 2003-10-11 | Ciba Sc Holding Ag | A compound, a photopolymerizible composition, a process for producing coatings and a method for causing a photoinitiator to accumulate at the surface of coatings |
| US20030032625A1 (en) * | 2001-03-29 | 2003-02-13 | Topo Target Aps | Succinimide and maleimide derivatives and their use as topoisomerase II catalytic inhibitors |
| DE10143079A1 (de) * | 2001-09-03 | 2003-05-15 | Zentaris Ag | Cyclische Indol- und Heteroindolderivate, deren Herstellung und Verwendung als Arzneimittel |
| US20050267303A1 (en) * | 2001-09-04 | 2005-12-01 | Zentaris Ag | Cyclic indole and heteroindole derivatives and methods for making and using as pharmaceuticals |
| WO2003063861A1 (fr) * | 2002-01-30 | 2003-08-07 | Sumitomo Pharmaceuticals Co., Ltd. | Inhibiteur de fibrose |
| US6800655B2 (en) | 2002-08-20 | 2004-10-05 | Sri International | Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents |
| US7223785B2 (en) | 2003-01-22 | 2007-05-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| US7098231B2 (en) | 2003-01-22 | 2006-08-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
| CA2565387A1 (en) * | 2004-05-03 | 2005-11-17 | Ilypsa, Inc. | Modulation of lysophosphatidylcholine and treatment of diet-induced conditions |
| EP1948656A2 (en) * | 2005-11-03 | 2008-07-30 | Ilypsa, Inc. | Azaindole compounds and use thereof as phospholipase-a2 inhibitors |
| US7666898B2 (en) * | 2005-11-03 | 2010-02-23 | Ilypsa, Inc. | Multivalent indole compounds and use thereof as phospholipase-A2 inhibitors |
| EP1951315A2 (en) * | 2005-11-03 | 2008-08-06 | Ilypsa, Inc. | Phospholipase inhibitors, including multi-valent phospholipase inhibitors, and use thereof, including as lumen-localized phospholipase inhibitors |
| CA2627353A1 (en) * | 2005-11-03 | 2007-05-18 | Ilypsa, Inc. | Indole compounds having c4-acidic substituents and use thereof as phospholipase-a2 inhibitors |
| WO2007056275A2 (en) * | 2005-11-03 | 2007-05-18 | Ilypsa, Inc. | Indole compounds having c4-amide substituents and use thereof as phospholipase-a2 inhibitors |
| US20090142832A1 (en) * | 2007-11-29 | 2009-06-04 | James Dalton | Indoles, Derivatives, and Analogs Thereof and Uses Therefor |
| CN102482278B (zh) | 2009-06-29 | 2015-04-22 | 因塞特公司 | 作为pi3k抑制剂的嘧啶酮类 |
| CN101704828A (zh) * | 2009-11-04 | 2010-05-12 | 中国科学院昆明植物研究所 | 山橙素类双吲哚化合物,其药物组合物及其制备方法和用途 |
| WO2011075643A1 (en) * | 2009-12-18 | 2011-06-23 | Incyte Corporation | Substituted heteroaryl fused derivatives as pi3k inhibitors |
| TW201130842A (en) * | 2009-12-18 | 2011-09-16 | Incyte Corp | Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors |
| US9193721B2 (en) | 2010-04-14 | 2015-11-24 | Incyte Holdings Corporation | Fused derivatives as PI3Kδ inhibitors |
| WO2011163195A1 (en) | 2010-06-21 | 2011-12-29 | Incyte Corporation | Fused pyrrole derivatives as pi3k inhibitors |
| TW201249844A (en) | 2010-12-20 | 2012-12-16 | Incyte Corp | N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors |
| US9108984B2 (en) | 2011-03-14 | 2015-08-18 | Incyte Corporation | Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors |
| US9126948B2 (en) | 2011-03-25 | 2015-09-08 | Incyte Holdings Corporation | Pyrimidine-4,6-diamine derivatives as PI3K inhibitors |
| KR101982475B1 (ko) | 2011-09-02 | 2019-05-27 | 인사이트 홀딩스 코포레이션 | Ｐｉ３ｋ 억제제로서 헤테로시클릴아민 |
| AR090548A1 (es) | 2012-04-02 | 2014-11-19 | Incyte Corp | Azaheterociclobencilaminas biciclicas como inhibidores de pi3k |
| WO2015191677A1 (en) | 2014-06-11 | 2015-12-17 | Incyte Corporation | Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors |
| KR20240132104A (ko) | 2015-02-27 | 2024-09-02 | 인사이트 홀딩스 코포레이션 | Pi3k 억제제의 염 및 이의 제조 공정 |
| US9988401B2 (en) | 2015-05-11 | 2018-06-05 | Incyte Corporation | Crystalline forms of a PI3K inhibitor |
| WO2016183060A1 (en) | 2015-05-11 | 2016-11-17 | Incyte Corporation | Process for the synthesis of a phosphoinositide 3-kinase inhibitor |
| CN106317169B (zh) * | 2015-06-23 | 2019-07-02 | 首都医科大学 | 双吲哚-二肽衍生物,其合成,抗血栓活性和制备抗血栓剂的应用 |
| WO2018024172A1 (en) * | 2016-08-05 | 2018-02-08 | The University Of Hong Kong | Platinum complexes and methods of use thereof |
| AU2020242287A1 (en) | 2019-03-21 | 2021-09-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | A Dbait molecule in combination with kinase inhibitor for the treatment of cancer |
| WO2020245208A1 (en) | 2019-06-04 | 2020-12-10 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of cd9 as a biomarker and as a biotarget in glomerulonephritis or glomerulosclerosis |
| EP4054579A1 (en) | 2019-11-08 | 2022-09-14 | Institut National de la Santé et de la Recherche Médicale (INSERM) | Methods for the treatment of cancers that have acquired resistance to kinase inhibitors |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3598583A (en) * | 1968-08-09 | 1971-08-10 | Itek Corp | Indomethylene dye bases and their utilization in photographic processes and compositions |
| FR2688220A1 (fr) * | 1992-03-06 | 1993-09-10 | Adir | Nouveaux derives de thiazolidine-2,4-dione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| AU6581094A (en) * | 1993-04-22 | 1994-11-08 | Nippon Shinyaku Co. Ltd. | Benzofurancarboxylic acid derivative and pharmaceutical composition |
| US5656643A (en) | 1993-11-08 | 1997-08-12 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase |
| DE69434294T2 (de) * | 1993-12-23 | 2005-12-29 | Eli Lilly And Co., Indianapolis | Proteinkinase c-inhibitoren |
| JPH08295688A (ja) * | 1995-04-28 | 1996-11-12 | Sharp Corp | ビスアゾ化合物、その中間体及びそれらの製造方法、並びにビスアゾ化合物を含有する電子写真感光体 |
| DE19547263C2 (de) * | 1995-12-07 | 1999-04-29 | Cardiotec Inc | Amidinohydrazone vom Benzo[b]furan abgeleiteter Ketone, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| BR9911017A (pt) | 1998-05-04 | 2001-02-06 | Asta Medica Ag | Derivados de indol e seu emprego para o tratamento de doenças malignas e outras, que se baseiam na proliferação de células patológicas |
-
1999
- 1999-04-22 BR BR9911017-2A patent/BR9911017A/pt not_active IP Right Cessation
- 1999-04-22 AT AT99927711T patent/ATE230394T1/de not_active IP Right Cessation
- 1999-04-22 TR TR2000/03206T patent/TR200003206T2/xx unknown
- 1999-04-22 SK SK1635-2000A patent/SK16352000A3/sk unknown
- 1999-04-22 JP JP2000547087A patent/JP2002514572A/ja not_active Withdrawn
- 1999-04-22 AU AU44975/99A patent/AU752464B2/en not_active Ceased
- 1999-04-22 EP EP99927711A patent/EP1109785B1/de not_active Expired - Lifetime
- 1999-04-22 CA CA002330756A patent/CA2330756C/en not_active Expired - Fee Related
- 1999-04-22 CN CNB998058033A patent/CN1151127C/zh not_active Expired - Fee Related
- 1999-04-22 WO PCT/DE1999/001214 patent/WO1999057117A2/de not_active Application Discontinuation
- 1999-04-22 DE DE59903921T patent/DE59903921D1/de not_active Expired - Fee Related
- 1999-04-22 ES ES99927711T patent/ES2190221T3/es not_active Expired - Lifetime
- 1999-04-22 HU HU0102563A patent/HUP0102563A3/hu unknown
- 1999-04-22 PL PL99346840A patent/PL346840A1/xx not_active Application Discontinuation
- 1999-04-22 DK DK99927711T patent/DK1109785T3/da active
- 1999-04-22 CZ CZ20003960A patent/CZ20003960A3/cs unknown
- 1999-04-22 IL IL13905699A patent/IL139056A0/xx not_active IP Right Cessation
- 1999-05-04 US US09/305,115 patent/US6407102B1/en not_active Expired - Fee Related
-
2000
- 2000-10-24 NZ NZ507735A patent/NZ507735A/xx unknown
- 2000-10-27 NO NO20005448A patent/NO317261B1/no unknown
- 2000-11-28 BG BG104996A patent/BG104996A/xx unknown
-
2001
- 2001-12-27 HK HK01109122A patent/HK1038354A1/xx not_active IP Right Cessation
-
2002
- 2002-05-03 US US10/137,653 patent/US6812243B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999057117A2 (de) | 1999-11-11 |
| HUP0102563A2 (hu) | 2001-11-28 |
| DE59903921D1 (de) | 2003-02-06 |
| CN1151127C (zh) | 2004-05-26 |
| EP1109785A2 (de) | 2001-06-27 |
| BR9911017A (pt) | 2001-02-06 |
| CA2330756C (en) | 2007-10-02 |
| US6407102B1 (en) | 2002-06-18 |
| NO317261B1 (no) | 2004-09-27 |
| CZ20003960A3 (cs) | 2002-04-17 |
| WO1999057117A3 (de) | 2001-04-12 |
| ES2190221T3 (es) | 2003-07-16 |
| NO20005448D0 (no) | 2000-10-27 |
| AU4497599A (en) | 1999-11-23 |
| NZ507735A (en) | 2003-04-29 |
| CN1310705A (zh) | 2001-08-29 |
| BG104996A (en) | 2001-07-31 |
| JP2002514572A (ja) | 2002-05-21 |
| ATE230394T1 (de) | 2003-01-15 |
| IL139056A0 (en) | 2001-11-25 |
| SK16352000A3 (sk) | 2002-07-02 |
| EP1109785B1 (de) | 2003-01-02 |
| HK1038354A1 (en) | 2002-03-15 |
| CA2330756A1 (en) | 1999-11-11 |
| HUP0102563A3 (en) | 2003-04-28 |
| PL346840A1 (en) | 2002-02-25 |
| AU752464B2 (en) | 2002-09-19 |
| TR200003206T2 (tr) | 2001-07-23 |
| US20030008898A1 (en) | 2003-01-09 |
| US6812243B2 (en) | 2004-11-02 |
| NO20005448L (no) | 2000-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1109785T3 (da) | Indolderivater og deres anvendelse til behandling af ondartede og andre sygdomme forårsaget af patologisk celleproliferation | |
| LU91657I2 (fr) | Tocéranibe et ses dérivés pharmaceutiquement acceptables (PALLADIA®) | |
| TR200002980T2 (tr) | İnhibe edici etkiye sahip ikame edilmiş indolinonlar | |
| DK1070056T3 (da) | Phthalazinon-PDE III/IV-inhibitorer | |
| TR200200928T2 (tr) | 2-pirazolin-5-on terkipleri | |
| CY1106933T1 (el) | Ενωσεις πυριμιδινης | |
| TR199900048T2 (xx) | Protein tirozin kinaz inhibit�rleri olarak bisiklik heteroaromatik bile�ikler | |
| TR200001174T2 (tr) | Protein tirozin kinaz ve protein serin/treonin kinaz inhibitörleri olarak ikameli oksindol türevleri | |
| NO20061194L (no) | Mitotiske kinesininbibitorer | |
| EA200501009A1 (ru) | Замещённые пирролопиразольные производные в качестве ингибиторов киназы | |
| TR200201505T2 (tr) | Terapötik maddeler olarak pirazolopirimidinler | |
| HRP20050059B8 (hr) | Novi inhibitori kinaza | |
| BR0108396A (pt) | Derivados de pirimidina-4-0na como inibidores de ldl-pla(2) | |
| YU21401A (sh) | Tetrahidropiridoetri | |
| EA200200058A1 (ru) | Пиримидин-2,4,6-трионовые ингибиторы металлопротеиназ | |
| DE60205776T2 (de) | Indolinon-derivative als protein-kinasehemmer | |
| ATE246184T1 (de) | Chinoline und deren therapeutische verwendung | |
| BRPI0407841A (pt) | inibidores heterocìclicos de quinase | |
| ATE305787T1 (de) | 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren | |
| DK1218494T3 (da) | Præparater og fremgangsmåder til inhibering af C2-cellecyklusstandsning og sensibilisering af celler til DNA-beskadigende midler | |
| EA200301005A1 (ru) | Замещенные в положении 6 индолиноны и их применение в качестве ингибиторов киназ | |
| HRP20050382B1 (hr) | Novi pirimidin-4,6-dikarboksamidi za selektivnu inhibiciju kolagenaza | |
| DE60036558D1 (de) | Phthalazinon-derivate als pde 4 hemmer | |
| ATE380810T1 (de) | Protein-tyrosine-kinase-inhibitoren | |
| BRPI0508881A (pt) | derivados de imidazol |